1
TMC278-TiDP15-C158 – A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278
Condition(s):HIV InfectionsLast Updated:November 20, 2012Completed